Skip to main content
Supplement ScienceSupplementScience
meta analysis5,666 participants

Saw Palmetto for BPH: Comparing Extracts and Trial Results

·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

The 2012 Cochrane review found no meaningful advantage of saw palmetto over placebo in its higher-quality long-term...

The 2012 Cochrane review found no meaningful advantage of saw palmetto over placebo in its higher-quality long-term trials. A 2018 review specific to hexanic Permixon included 15 randomized and 12 observational studies and found some benefits. A 2019 Chinese trial compared an extract with placebo, not tamsulosin. These findings do not establish that all saw palmetto products replace prescription treatment.

Key Findings

  • Cochrane 2012 included 32 randomized studies and 5,666 men. Its pooled high-quality long-term symptom trials showed no superiority over placebo.
  • The product-specific 2018 review included 27 studies: 15 randomized trials and 12 observational studies, totaling 5,800 participants. It was not 27 RCTs with 4,957 men.
  • For hexanic Permixon, the 2018 analysis reported 0.64 fewer nightly voids and a 2.75 mL/s greater increase in maximum flow versus placebo. These findings are specific to that extract and analysis.
  • Ye 2019 randomized 354 men to 320 mg/day of Serenoa repens extract or placebo for 24 weeks and reported improved symptoms and flow. It was not a 206-person noninferiority comparison against tamsulosin.
  • Results across extracts and study designs differ. Similarity in selected comparisons does not establish a first-line replacement for prescribed BPH care.

Study Details

Serenoa repens for benign prostatic hyperplasia
Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ — Cochrane Database Syst Rev (2012)
Cochrane review: higher-quality long-term trials found no meaningful advantage over placebo for symptoms or flow.
5,666 participantsHigh
Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, et al. — Urology (2019)
Placebo-controlled Chinese trial of 320 mg/day for 24 weeks reported improved symptom scores and urinary flow; no tamsulosin arm.
354 participantsModerate
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, et al. — BJU Int (2018)
Review of 15 RCTs and 12 observational studies restricted to hexanic Permixon; some urinary outcomes favored this extract.
5,800 participantsModerate

Practical Takeaway

New or persistent urinary symptoms require assessment. If considering saw palmetto, discuss the exact extract, conflicting placebo-controlled evidence and monitoring with the clinician. Do not interpret product-specific research as proof that any 320 mg supplement equals tamsulosin.

Summary

Cochrane trials, a product-specific review and a later placebo-controlled trial reported differing results for saw palmetto in lower urinary tract symptoms. Their designs and extracts should be distinguished.

Related Supplements

Saw Palmetto

Related Conditions

Prostate HealthHair Loss & Thinning Hair

Product Reviews

Best Saw Palmetto Supplements
See our ranked picks →

Learn More

Best Supplements for Men Over 40

Frequently Asked Questions

Does saw palmetto reliably improve BPH symptoms?

Results differ. Higher-quality long-term Cochrane trials found no meaningful benefit over placebo, while some extract-specific studies reported improvements. The exact product and study design matter.

Was the 2019 Chinese trial compared with Flomax?

No. It randomized 354 men to saw palmetto extract or placebo. It cannot be cited as a head-to-head tamsulosin noninferiority trial.

Do these results apply to every saw palmetto supplement?

No. The2018 positive synthesis was limited to the hexanic extract Permixon. Different extracts and raw berry powders should not be treated as equivalent.

Can saw palmetto replace an evaluation for urinary symptoms?

No. A clinician should assess persistent or worsening symptoms and determine whether treatment or further testing is needed.

Continue Reading

Supplement Guide

Saw Palmetto

Better-quality trials do not support saw palmetto alone for BPH urinary symptoms. A studied dose does not establish benefit or equivalence to prescription treatment.

Product Comparison

Best Saw Palmetto Supplements

See our ranked picks

Condition Guide

Prostate Health

References

  1. Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ (2012). Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev. DOI PubMed
  2. Ye Z, Huang J, Zhou L, Chen S, Wang Z, Ma L, et al. (2019). Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Urology. DOI PubMed
  3. Vela-Navarrete R, Alcaraz A, Rodríguez-Antolín A, Miñana López B, Fernández-Gómez JM, Angulo JC, et al. (2018). Efficacy and safety of a hexanic extract of Serenoa repens (Permixon® ) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies. BJU Int. DOI PubMed